State Ledger
Company profile

Theriva Biologics, Inc. CIK 894158

Ticker
TOVX (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Rockville, MD 20850
Fiscal year end
2025 (FY)
Market Data
Close
$0.21
Change
-$0.02
Change %
-7.50%
Volume
6,160

TOVX · trading date Oct 9, 2026 · previous close $0.23 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$25.25M
Total assets
$38.24M
Total liabilities
$22.86M
Stockholders' equity
$15.38M
Cash & equivalents
$13.06M
Operating income
-$24.05M
Operating cash flow
-$16.67M
Capital expenditures
$35.0K

Fiscal year 2025, via 10-K filed 2026-03-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$16.70M
Free cash flow margin
—
Liabilities / assets
59.8%
Equity / assets
40.2%
CapEx / revenue
—
Operating cash flow / net income
0.66×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$25.25M $38.24M $22.86M $15.38M
2024 — -$25.65M $35.35M $16.29M $19.07M
2023 — -$18.35M $55.22M $15.52M $36.96M
2022 — -$19.69M $71.86M $17.30M $51.83M
2021 — -$14.27M $70.37M $4.96M $65.41M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form S-8
2026-08-24
Financials filed via
Form 10-K
filed 2026-03-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Rockville, MD 20850
9605 MEDICAL CENTER DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Maryland — Public Companies